Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...

Urinary tract infections (UTIs ... Newer agents are now available for the treatment of UTI among older adults, targeting both the usual and the multiresistant uropathogens. Rational use of ...

The world faces a growing crisis in antifungal resistance, with fungal infections causing millions of deaths annually.

They can appear anywhere from the anus to the lower back, bringing symptoms like itching, inflammation, swelling, and bumps.

Researchers investigated characteristics of adolescent and young adult patients with HCC and risk factors that affect survival.

The treatment provides protective antibodies to infants. It will be available to all Ontario babies born in 2024 as well as ...

“Awareness is key to promoting voluntary vaccinations by educating people on the need, benefits and safety of vaccines, especially for preventing lung infections. It reduces vaccine hesitancy ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Scientists warn of a silent pandemic as deadly fungal infections evolve demanding urgent global action to combat antifungal resistance ...

All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for ...

Learn about leukaemia, its types, symptoms, and treatment options for better understanding and early diagnosis.